Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight.
Mack CM, Soares CJ, Wilson JK, Athanacio JR, Turek VF, Trevaskis JL, Roth JD, Smith PA, Gedulin B, Jodka CM, Roland BL, Adams SH, Lwin A, Herich J, Laugero KD, Vu C, Pittner R, Paterniti JR Jr, Hanley M, Ghosh S, Parkes DG. Mack CM, et al. Among authors: paterniti jr jr. Int J Obes (Lond). 2010 Feb;34(2):385-95. doi: 10.1038/ijo.2009.238. Epub 2009 Nov 24. Int J Obes (Lond). 2010. PMID: 19935749
1-Hydroxyalkyl-3-phenylthioureas as novel HDL-elevating agents.
Coppola GM, Damon RE, Eskesen JB, France DS, Paterniti JR Jr. Coppola GM, et al. Among authors: paterniti jr jr. Bioorg Med Chem Lett. 2005 Feb 1;15(3):809-12. doi: 10.1016/j.bmcl.2004.10.094. Bioorg Med Chem Lett. 2005. PMID: 15664862
Thiourea-based gemfibrozil analogues as HDL-elevating agents.
Coppola GM, Damon RE, Eskesen JB, France DS, Paterniti JR Jr. Coppola GM, et al. Among authors: paterniti jr jr. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2439-42. doi: 10.1016/s0960-894x(02)00435-3. Bioorg Med Chem Lett. 2002. PMID: 12161152
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models.
Etgen GJ, Oldham BA, Johnson WT, Broderick CL, Montrose CR, Brozinick JT, Misener EA, Bean JS, Bensch WR, Brooks DA, Shuker AJ, Rito CJ, McCarthy JR, Ardecky RJ, Tyhonas JS, Dana SL, Bilakovics JM, Paterniti JR Jr, Ogilvie KM, Liu S, Kauffman RF. Etgen GJ, et al. Among authors: paterniti jr jr. Diabetes. 2002 Apr;51(4):1083-7. doi: 10.2337/diabetes.51.4.1083. Diabetes. 2002. PMID: 11916929
39 results